Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             18 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An open-label feasibility study of nintedanib combined with docetaxel in Japanese patients with locally advanced or metastatic lung adenocarcinoma after failure of first-line chemotherapy Yamamoto, Noboru
2018
82 4 p. 685-694
artikel
2 A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer Greil, Richard
2018
82 4 p. 695-706
artikel
3 A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2) Tanaka, Yusuke
2018
82 4 p. 585-592
artikel
4 A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors Liu, Stephen V.
2018
82 4 p. 723-732
artikel
5 Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients Akiyama, Kana
2018
82 4 p. 717-721
artikel
6 Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer Yamazaki, Haruhiko
2018
82 4 p. 649-654
artikel
7 Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1 Jain, Mukul R.
2018
82 4 p. 635-647
artikel
8 Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071) Moehler, Markus
2018
82 4 p. 733-739
artikel
9 Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand–foot skin reactions in sorafenib-treated patients Saito, Kosuke
2018
82 4 p. 677-684
artikel
10 Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy Shibuya, Hitoshi
2018
82 4 p. 661-668
artikel
11 Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial Zhang, Wen
2018
82 4 p. 655-660
artikel
12 Pharmacodynamic modelling of resistance to epidermal growth factor receptor inhibition in brain metastasis mouse models Martin, Emma C.
2018
82 4 p. 669-675
artikel
13 Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer Nishimura, Junichi
2018
82 4 p. 707-716
artikel
14 Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer Huang, Weiwei
2018
82 4 p. 607-613
artikel
15 Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation Ni, Feng
2018
82 4 p. 593-605
artikel
16 Skin toxicity with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of 65 randomized controlled trials Li, Jing
2018
82 4 p. 571-583
artikel
17 The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer Yamaguchi, Kyoko
2018
82 4 p. 625-633
artikel
18 Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects Zhang, Hong
2018
82 4 p. 615-623
artikel
                             18 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland